Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: Pharmacological and behavioral genetics evidence

Frontiers in Behavioral Neuroscience

Volumn , Issue JULY, 2012, Pages

  Hollander, Jonathan A ^a,b   Pham, Don ^a,b   Fowler, Christie D ^a,b   Kenny, Paul J ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; Cocaine; Hypocretin; Intracranial self stimulation; Intravenous self administration; Knockout mice; Orexin; Reward

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; COCAINE; OREXIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR GENETICS; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FEMALE; FOOD INTAKE; GENOTYPE; MALE; MOTIVATION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; REINFORCEMENT; REWARD;

EID: 84864390270     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00047     Document Type: Article

References (62)

1. Ahmed, S.H., Kenny, P.J., Koob, G.F., and Markou, A. (2002). Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci 5, 625-626.
2. Al-Barazanji, K.A., Wilson, S., Baker, J., Jessop, D.S., and Harbuz, M.S. (2001). Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotrophin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 13, 421-424.
3. Aston-Jones, G., Smith, R.J., Moorman, D.E., and Richardson, K.A. (2009). Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl 1, 112-121.
4. Baldo, B.A., Daniel, R.A., Berridge, C.W., and Kelley, A.E. (2003). Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464, 220-237.
5. Bespalov, A., Dumpis, M., Piotrovsky, L., and Zvartau, E. (1994). Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur J Pharmacol 264, 233-239.
6. Borgland, S.L., Chang, S.J., Bowers, M.S., Thompson, J.L., Vittoz, N., Floresco, S.B., Chou, J., Chen, B.T., and Bonci, A. (2009). Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29, 11215-11225.
7. Borgland, S.L., Taha, S.A., Sarti, F., Fields, H.L., and Bonci, A. (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589-601.
8. Borgland, S.L., Ungless, M.A., and Bonci, A. (2010). Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Res 1314, 139-144.
9. Boutrel, B., Kenny, P.J., Specio, S.E., Martin-Fardon, R., Markou, A., Koob, G.F., and De Lecea, L. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102, 19168-19173.
10. Bruijnzeel, A.W., Prado, M., and Isaac, S. (2009). Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stressinduced relapse. Biol Psychiatry 66, 110-117.
11. Bruijnzeel, A.W., Zislis, G., Wilson, C., and Gold, M.S. (2007). Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32, 955-963.
12. Carlezon, W.A., Jr., and Chartoff, E.H. (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2, 2987-2995.
13. Dackis, C.A., and O'brien, C.P. (2001). Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 21, 111-117.
14. De Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., Frankel, W.N., Van Den Pol, A.N., Bloom, F.E., Gautvik, K.M., and Sutcliffe, J.G. (1998). The hypo cretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95, 322-327.
15. Dileone, R.J., Georgescu, D., and Nestler, E.J. (2003). Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci 73, 759-768.
16. Espana, R.A., Oleson, E.B., Locke, J.L., Brookshire, B.R., Roberts, D.C., and Jones, S.R. (2010). The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 31, 336-348.
17. Esposito, R.U., Motola, A.H., and Kornetsky, C. (1978). Cocaine: acute effects on reinforcement thresholds for self-stimulation behavior to the medial forebrain bundle. Pharmacol Biochem Behav 8, 437-439.
18. Fish, E.W., Riday, T.T., Mcguigan, M.M., Faccidomo, S., Hodge, C.W., and Malanga, C.J. (2010). Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res 34, 81-89.
19. Fowler, C.D., Lu, Q., Johnson, P.M., Marks, M.J., and Kenny, P.J. (2011). Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature.
20. Gautvik, K.M., De Lecea, L., Gautvik, V.T., Danielson, P.E., Tranque, P., Dopazo, A., Bloom, F.E., and Sutcliffe, J.G. (1996). Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci U S A 93, 8733-8738.
21. Harris, G.C., Wimmer, M., and Aston-Jones, G. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437, 556-559.
22. Harrison, A.A., Gasparini, F., and Markou, A. (2002). Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl) 160, 56-66.
23. Hollander, J.A., Lu, Q., Cameron, M.D., Kamenecka, T.M., and Kenny, P.J. (2008). Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 105, 19480-19485.
24. Hondo, M., Nagai, K., Ohno, K., Kisanuki, Y., Willie, J.T., Watanabe, T., Yanagisawa, M., and Sakurai, T. (2010). Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states. Acta Physiol (Oxf) 198, 287-294.
25. Hungs, M., and Mignot, E. (2001). Hypocretin/orexin, sleep and narcolepsy. Bioessays 23, 397-408.
26. Ida, T., Nakahara, K., Murakami, T., Hanada, R., Nakazato, M., and Murakami, N. (2000). Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270, 318-323.
27. James, M.H., Charnley, J.L., Levi, E.M., Jones, E., Yeoh, J.W., Smith, D.W., and Dayas, C.V. (2011). Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 14, 684-690.
28. Kenny, P.J. (2007). Brain reward systems and compulsive drug use. Trends Pharmacol Sci 28, 135-141.
29. Kenny, P.J. (2011). Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 97, 700-707.
30. Kenny, P.J., and Markou, A. (2005). Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci 25, 6208-6212.
31. Kenny, P.J., Paterson, N.E., Boutrel, B., Semenova, S., Harrison, A.A., Gasparini, F., Koob, G.F., Skoubis, P.D., and Markou, A. (2003). Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann N Y Acad Sci 1003, 415-418.
32. Kornetsky, C., and Esposito, R.U. (1979). Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38, 2473-2476.
33. Lawrence, A.J., Cowen, M.S., Yang, H.J., Chen, F., and Oldfield, B. (2006). The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148, 752-759.
34. Lubkin, M., and Stricker-Krongrad, A. (1998). Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253, 241-245.
35. Macey, D.J., Koob, G.F., and Markou, A. (2000). CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res 866, 82-91.
36. Maldonado-Irizarry, C.S., Stellar, J.R., and Kelley, A.E. (1994). Effects of cocaine and GBR-12909 on brain stimulation reward. Pharmacol Biochem Behav 48, 915-920.
37. Markou, A., and Koob, G.F. (1992). Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51, 111-119.
38. Mieda, M., Hasegawa, E., Kisanuki, Y.Y., Sinton, C.M., Yanagisawa, M., and Sakurai, T. (2011). Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 31, 6518-6526.
39. Moore, R.Y., Abrahamson, E.A., and Van Den Pol, A. (2001). The hypocretin neuron system: an arousal system in the human brain. Arch Ital Biol 139, 195-205.
40. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res 827, 243-260.
41. Narita, M., Nagumo, Y., Hashimoto, S., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., and Suzuki, T. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26, 398-405.
42. Pellegrino, L.J., Pellegrino, A. S., Cushman, A. J. (ed.). (1979). A Stereotaxic Atlas of the Rat Brain. New York: Plenum Press.
43. Peyron, C., Tighe, D.K., Van Den Pol, A.N., De Lecea, L., Heller, H.C., Sutcliffe, J.G., and Kilduff, T.S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996-10015.
44. Porter, R.A., Chan, W.N., Coulton, S., Johns, A., Hadley, M.S., Widdowson, K., Jerman, J.C., Brough, S.J., Coldwell, M., Smart, D., Jewitt, F., Jeffrey, P., and Austin, N. (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorg Med Chem Lett 11, 1907-1910.
45. Riday, T.T., Fish, E.W., Robinson, J.E., Jarrett, T.M., Mcguigan, M.M., and Malanga, C.J. (2012). Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss- Webster mice. Brain Res 1431, 53-61.
46. Rodgers, R.J., Halford, J.C., Nunes De Souza, R.L., Canto De Souza, A.L., Piper, D.C., Arch, J.R., Upton, N., Porter, R.A., Johns, A., and Blundell, J.E. (2001). SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13, 1444-1452.
47. Russell, S.H., Small, C.J., Dakin, C.L., Abbott, C.R., Morgan, D.G., Ghatei, M.A., and Bloom, S.R. (2001). The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 13, 561-566.
48. Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8, 171-181.
49. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richarson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., Mcnulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J., and Yanagisawa, M. (1998). Orexins and orexin receptors: a family of hypothalamicneuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 1-696.
50. Sasaki, K., Suzuki, M., Mieda, M., Tsujino, N., Roth, B., and Sakurai, T. (2011). Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One 6, e20360.
51. Smart, D., Sabido-David, C., Brough, S.J., Jewitt, F., Johns, A., Porter, R.A., and Jerman, J.C. (2001). SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132, 1179-1182.
52. Smith, M.I., Piper, D.C., Duxon, M.S., and Upton, N. (2003). Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci Lett 341, 256-258.
53. Smith, R.J., See, R.E., and Aston-Jones, G. (2009). Orexin hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 30, 493-503.
54. Szekely, M. (2006). Orexins, energy balance, temperature, sleep-wake cycle. Am J Physiol Regul Integr Comp Physiol 291, R530-532.
55. Thompson, J.L., and Borgland, S.L. (2011). A role for hypocretin/orexin in motivation. Behav Brain Res 217, 446-453.
56. Tsunematsu, T., Kilduff, T.S., Boyden, E.S., Takahashi, S., Tominaga, M., and Yamanaka, A. (2011). Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 31, 10529-10539.
57. Van Den Pol, A.N., Patrylo, P.R., Ghosh, P.K., and Gao, X.B. (2001). Lateral hypothalamus: early developmental expression and response to hypocretin (orexin). J Comp Neurol 433, 349-363.
58. Wang, B., You, Z.B., and Wise, R.A. (2009). Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 65, 857-862.
59. Willie, J.T., Chemelli, R.M., Sinton, C.M., Tokita, S., Williams, S.C., Kisanuki, Y.Y., Marcus, J.N., Lee, C., Elmquist, J.K., Kohlmeier, K.A., Leonard, C.S., Richardson, J.A., Hammer, R.E., and Yanagisawa, M. (2003). Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715-730.
60. Willie, J.T., Chemelli, R.M., Sinton, C.M., and Yanagisawa, M. (2001). To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24, 429-458.
61. Yoshimichi, G., Yoshimatsu, H., Masaki, T., and Sakata, T. (2001). Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 226, 468-476.
62. Zhang, G.C., Mao, L.M., Liu, X.Y., and Wang, J.Q. (2007). Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration. J Neuro chem 103, 400-407.